- Investing Ideas
- /
- Danish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Danish Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
NOVO B | DKK 750.90 | 5.6% | 4.8% | DKK 3.3t | DKK 938.04 | PE35.2x | E14.4% | 1.3% | ||
ALK B | DKK 158.50 | 0.3% | 69.2% | DKK 35.1b | DKK 181.20 | PE44.7x | E21.5% | 0% |
Page 1 of 1